Elevance Health, Inc. · Hospital & Medical Service Plans

ELV

Low riskNext report: Around Jan 27, 2027 (est.)

View price ↗

The short version

A profitable company with steady sales. Institutions are adding.

Going well

Profitable every year for 10 years
Sales up 13% last year
Brings in more cash than it spends

Money moves

Insiders sold $4.7M in the last 30 days
Institutions added 4.6% to their holdings in the quarter ending June 2026 (832 bought, 642 sold)
Held by Seth Klarman (Baupost)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$431.37-1.9% that day

Company value: $93.2B; Share price times all shares
Price vs profit (P/E): 18.3x; You pay about $18 for each $1 of yearly profit
Price vs sales: 0.46x; Company value is 0.46 times a year of sales
Cash vs value: 11%; Cash as a share of company value
Debt vs value: 34%; Debt as a share of company value

From ELV's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Sep '26

$51.4B+1.4% vs a year earlier

Dec '23Tap a barSep '26

Last 12 months: $201.8B, up 3.6% from the 12 months before. Over 5 years, sales grew about 10% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of ELV. Starting points are the company's recent numbers.

Sales growth+4% a yearRecently: +3.6% a yearProfit margin3%Last 12 months: 2.5%P/E at the end18xToday: 18.3x. Many steady companies trade at 12x to 25xShare count change-2% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$245.6B

Profit in 5 years$7.4B

Price these guesses point to$678.97+57% vs $431.37 todayAbout +9.5% a year, before dividends

What today's price needs: with a 3% margin and a 18x P/E, sales could shrink about 5.0% a year for 5 years and still match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

3/6Mixed

MissReturn on equity 15%+Earns a lot on the money owners have in the business.13.3%
MissDebt under half of equityNot relying on borrowed money.0.73x equity
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.2.8%
PassProfitable every yearSteady profits, not one good year.10 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$3.2B
PassShare count not growingNot diluting owners. Falling means buybacks.-7.5% in 3 years

Revenue: $199.1B; +12.5% vs prior year
5-year growth: +10.3%/yr; revenue, per year
Total debt: $31.9B; 0.73x equity
Current ratio: 1.54x; short-term assets / bills due

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Sep 30, 2026

Reported Oct 21Before open6:01 am ET

Revenue: $51.4B; +1.4% YoY
EPS: $6.27; vs $5.32
Op. margin: 2.5%; -0.1 pts
Gross margin: 89.0%; -0.4 pts
Free cash flow: $1.0B
Share count: -2.7%; vs a year ago

Insider rating

Last 90 days

26Selling

1 insider sold $4.7M (not pre-planned)

50 is neutral. Buying by more insiders, top executives and bigger stakes raises it. Selling lowers it; pre-planned sales count less.

Weekly insider trend

13 weeks agoBoughtSoldThis week

Filing buzz

Last 7 days vs normal

89/ 100

This week: 4
Normal week: 0.5
vs normal: 8.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Accumulating+4.6%

Institutions added 4.6% to their holdings. 832 bought, 642 sold.

Shares held by institutions203.8M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

-2.7%

Cash runwayAt last year's cash burn

Cash flow positive

Debt to equityLatest balance sheet: debt compared with what owners have

0.7x · $30.8B debt

Shares outstandingLatest reported

216M

Earnings reports

Last 12

Next reportAround Jan 27, 2027 (est.)Estimated from the same quarter last year

Results filedOct 21
Results filedJul 15
Results filedApr 22
Results filedJan 28
Results filedOct 21, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

No offerings, red flags or new big holders. Clean record.

Insider trades

Open-market buys and sells, last 90 days

Bought$00 insiders

Sold$4.7M1 insider, 0 pre-planned

Insider	Trade	Shares	Avg price	Value	Owns after	Date
Mark KayeEVP & CFO	Sell	11K	$440.13	$4.7M	20K	Oct 22Filing ↗
-34.7% of their holdings $434.00 to $447.19 across 13 trades Not a pre-planned sale Filed 1 day after